| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.555 | 3.622 | 2.233 | 1.031 | 1.412 | 600 | 0 | 6.651 | 3.032 | 201 |
| Total Income - EUR | 5.555 | 3.634 | 2.233 | 1.031 | 1.412 | 600 | 0 | 6.651 | 3.032 | 201 |
| Total Expenses - EUR | 1.461 | 940 | 741 | 998 | 349 | 311 | 603 | 720 | 3.461 | 1.373 |
| Gross Profit/Loss - EUR | 4.094 | 2.694 | 1.492 | 33 | 1.063 | 288 | -603 | 5.931 | -429 | -1.172 |
| Net Profit/Loss - EUR | 3.928 | 2.585 | 1.425 | 2 | 1.020 | 270 | -603 | 5.736 | -469 | -1.172 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Intermed Tifm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.136 | 645 |
| Current Assets | 1.483 | 841 | 16 | 14 | 165 | 7 | 0 | 3.402 | 1.700 | 1.002 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 980 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 283 | 282 |
| Cash | 503 | 841 | 16 | 14 | 165 | 7 | 0 | 3.402 | 1.416 | 721 |
| Shareholders Funds | -7.476 | -4.815 | -3.308 | -3.246 | -2.162 | -1.851 | -2.413 | 3.315 | 2.835 | 1.647 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.960 | 5.656 | 3.324 | 3.259 | 2.327 | 1.858 | 2.413 | 87 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Intermed Tifm Srl